Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastrointestinal adverse reactions and metabolism-nutrition disorders associated with hypomethylating agents: a pharmacovigilance study with exploratory mechanistic analysis.

Frontiers in nutrition·2026
Same author

Balancing NOM Removal and Polymer Stability in PVC Microplastics: A Comparative Evaluation of H<sub>2</sub>O<sub>2</sub> Digestion Protocols.

Bulletin of environmental contamination and toxicology·2026
Same author

Fatty Acid Binding Protein 5 Mediates Astrocytic Pyroptosis and Neuroinflammation in Epilepsy via cGAS/STING Pathway.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Histone H1 promotes silencing of unintegrated HIV-1 DNA.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Engineering <i>Saccharomyces cerevisiae</i> for Surface Display of a Functional H5 Influenza Virus-Specific Nanobody.

Microorganisms·2026
Same author

Diagnostic Value of Upright-Supine Imaging and Its Association with Postoperative Outcomes in Degenerative Lumbar Spondylolisthesis - A Two-Year PROM Based Comparison with Flexion Extension Radiographs.

The spine journal : official journal of the North American Spine Society·2026

Related Experiment Video

Updated: Jan 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K

TransGAT-DTA: A multi-task framework for drug-target affinity prediction and conditional molecule generation.

Xiaorui Huang1, Xingyu Liu1, Maoyuan Zhou1

  • 1Academy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.

Biochemical and Biophysical Research Communications
|January 17, 2026
PubMed
Summary

This study introduces TransGAT-DTA, a novel multi-task learning framework for drug discovery. It simultaneously predicts drug-target affinity and generates targeted molecules, improving efficiency and accuracy in identifying new drug candidates.

Keywords:
Deep learningDrug–target affinity predictionGraph attention networksMolecular generationMulti-task learning

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

953

Related Experiment Videos

Last Updated: Jan 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

953

Area of Science:

  • Computational chemistry
  • Machine learning in drug discovery
  • Bioinformatics

Background:

  • Drug discovery is hindered by the time and cost of identifying molecules that interact with target proteins.
  • Existing machine learning models often operate in single-task settings, limiting their ability to address both affinity prediction and molecule generation concurrently.

Purpose of the Study:

  • To develop a multi-task learning framework, TransGAT-DTA, capable of simultaneous drug-target affinity prediction and targeted molecule generation.
  • To overcome the limitations of single-task models in computational drug discovery.

Main Methods:

  • Utilized a multi-task learning framework integrating a shared graph-Transformer for molecular features and gated CNNs for protein sequences.
  • Implemented a learnable alignment module for cross-modal feature integration.
  • Employed a dynamic gradient coordination mechanism and conditional control attention for balanced optimization and guided molecule generation.

Main Results:

  • TransGAT-DTA demonstrated reduced mean squared error in affinity prediction compared to single-task models.
  • Successfully generated high-quality, target-specific molecules.
  • The end-to-end design mitigated error accumulation, offering robust bidirectional target-molecule optimization.

Conclusions:

  • TransGAT-DTA provides an effective framework for simultaneous drug-target affinity prediction and molecule generation.
  • The model enhances efficiency and accuracy in drug discovery pipelines.
  • Establishes a foundation for advancements in multi-target drug discovery.